Citation, DOI, disclosures and article data
At the time the article was created Yuranga Weerakkody had no recorded disclosures.View Yuranga Weerakkody's current disclosures
Lupus anticoagulant refers to an immunoglobulin that binds to phospholipids and proteins associated with cell membranes. The name lupus "anticoagulant" is in fact a misnomer as it is a prothrombotic agent. Patients with lupus anticoagulant have a primary hypercoagulable state and a greater propensity for thrombosis.
- 1. Molad Y, Sidi Y, Gornish M, Lerner M, Pinkhas J, Weinberger A. Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions. (1992) The Journal of rheumatology. 19 (4): 556-61. Pubmed
- 2. Vittorio Pengo, Alessandra Biasiolo, Paolo Gresele, Francesco Marongiu, Nicoletta Erba, Fabio Veschi, Angelo Ghirarduzzi, Doris Barcellona, Armando Tripodi. A Comparison of Lupus Anticoagulant–Positive Patients With Clinical Picture of Antiphospholipid Syndrome and Those Without. (2007) Arteriosclerosis, Thrombosis, and Vascular Biology. 27 (12): e309-10. doi:10.1161/ATVBAHA.107.153536 - Pubmed
- 3. Matthew R. Kovacs, Alejandro Lazo-Langner, Martha L Louzada, Michael J. Kovacs. Long Term Monitoring of Patients with Positive Lupus Anticoagulant and Antiphospholipid Antibodies. Are All Cases Persistently Positive?. (2016) Blood. 128 (22): 1452.